VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $69.00K in the quarter ending June 30, 2025, a decrease of -65.15%. This brings the company's revenue in the last twelve months to $476.00K, down -2.06% year-over-year. In the year 2024, VYNE Therapeutics had annual revenue of $501.00K with 18.16% growth.

• Revenue (ttm): $476.00K
• Revenue Growth: -2.06%
• P/S Ratio: 37.00
• Revenue / Employee: $36,615
• Employees: 13
• Market Cap: 10.52M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	501.00K	77.00K	18.16%
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%
Dec 31, 2020	20.99M	20.55M	4,638.83%
Dec 31, 2019	443.00K	-3.15M	-87.68%
Dec 31, 2018	3.60M	-987.00K	-21.54%
Dec 31, 2017	4.58M	3.91M	579.82%
Dec 31, 2016	674.00K	-	-
Dec 31, 2015	-	-	-